Rakuten Medical teams up with LOTTE Biologics to boost production of innovative cancer therapy
EU clears Eylea 8 mg for retinal vein occlusion, expanding use of long-acting eye therapy
HDFC Bank to rally 1,500 staff at Tata Mumbai Marathon 2026 to drive cancer awareness
Bayer welcomes the U.S. Supreme Court decision to review Durnell case in the Roundup litigation
EMA and FDA unveil joint AI principles to transform drug revelopment
FDA finds no clear link between popular diabetes, weight-loss drugs and suicidal thoughts
Bayer acquires Attralus’ cardiac amyloidosis imaging agents
Avantium and Packamama join forces to revolutionise wine packaging with plant-based polymer
Vetter advances next-gen syringe closure system towards 2027 launch
Zydus receives final approval from USFDA for Eltrombopag Tablets
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with mCSCC or laCSCC who are not candidates for curative surgery or curative radiation
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
